prostratin has been researched along with Papilloma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balmain, A; Delrosario, R; Galeas, J; Holderfield, M; McCormick, F; To, MD; Wang, MT | 1 |
Blumberg, PM; Krsmanovic, L; Szallasi, Z | 1 |
2 other study(ies) available for prostratin and Papilloma
Article | Year |
---|---|
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.
Topics: Amino Acid Sequence; Animals; Animals, Genetically Modified; Calmodulin; Cell Line, Tumor; Disease Models, Animal; Female; Genes, ras; Humans; Mice; Molecular Sequence Data; Pancreatic Neoplasms; Papilloma; Phorbol Esters; Phosphorylation; Protein Binding; Proto-Oncogene Proteins p21(ras); Receptors, Cell Surface; Wnt Signaling Pathway | 2015 |
Nonpromoting 12-deoxyphorbol 13-esters inhibit phorbol 12-myristate 13-acetate induced tumor promotion in CD-1 mouse skin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Mice; Papilloma; Phorbol Esters; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1993 |